Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

StemCells Inc

+ Add to Watchlist


0.6131 USD 0.0081 1.34%

As of 20:10:00 ET on 05/21/2015.

Company Profile for StemCells Inc (STEM)

StemCells, Inc. is a biotechnology company. The Company discovers, develops, and commercializes stem cell-based therapies to treat diseases of the central nervous system, liver, and the pancreas. StemCells seeks to repair or repopulate neural, or other tissue that has been damaged or lost as a result of disease or injury.

Contact Information

StemCells Inc

3155 Porter Drive
Palo Alto, CA 94304
United States
Phone: 1-650-475-3100
Fax: 1-650-475-3101

Key Executives for StemCells Inc (STEM)

Martin M McGlynnChief Executive OfficerIan J MasseyPresident/COO
Gregory T SchiffmanExec VP:Finance/CFOAnn TsukamotoExec VP:Strategic Alliances
Stephen HuhnVP:CNS Clinical Rsch/Chief Medical OfcrKenneth B Stratton "Ken"Secretary/General Counsel

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil